Publications by authors named "Ariel Raskin"

Claim this Profile
I
Induction of hemagglutinin stalk reactive antibodies by the administration of a live-attenuated influenza virus vaccine in children.
Juan Manuel Carreño, Philip Meade, Na Fatimata Sogodogo, Kaori Sano, Johnstone Tcheou, Ariel Raskin

iScience· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial.
Vu Dinh Thiem, Dang Duc Anh, Vu Hai Ha, Nguyen Van Thom, Tran Cong Thang, Ariel Raskin

Vaccine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination.
Jordan J Clark, Irene Hoxie, Daniel C Adelsberg, Iden A Sapse, Robert Andreata-Santos, Ariel Raskin

Cell Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023.
Juan Manuel Carreño, Abram L Wagner, Brian Monahan, Gagandeep Singh, Daniel Floda, Ariel Raskin

Nat Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase.
Komal Srivastava, Juan Manuel Carreño, Charles Gleason, Brian Monahan, Gagandeep Singh, Ariel Raskin

Immunity· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination.
Jordan Clark, Irene Hoxie, Daniel C Adelsberg, Iden A Sapse, Robert Andreata-Santos, Ariel Raskin

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ.1.1 or XBB.1.5.
Anass Abbad, Temima Yellin, Gagandeep Singh, Miriam Fried, Ariel Raskin

Cell Rep Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination.
Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata

Sci Transl Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants.
J Andrew Duty, Thomas Kraus, Heyue Zhou, Yanliang Zhang, Namir Shaabani, Ariel Raskin

Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer.
Philip C Mack, Jorge E Gomez, Ananda M Rodilla, Juan Manuel Carreño, Chih-Yuan Hsu, Ariel Raskin

Cancer Cell· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam.
Anh Duc Dang, Thiem Dinh Vu, Ha Hai Vu, Van Thanh Ta, Anh Thi Van Pham, Ariel Raskin

Vaccine· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron.
Juan Manuel Carreño, Hala Alshammary, Johnstone Tcheou, Gagandeep Singh, Ariel J Raskin

Nature· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats.
Johnstone Tcheou, Ariel Raskin, Gagandeep Singh, Hisaaki Kawabata, Dominika Bielak

Front Immunol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients.
Juan Manuel Carreño, Hala Alshammary, Gagandeep Singh, Ariel Raskin, Fatima Amanat

EBioMedicine· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
Florian Krammer, Komal Srivastava, Hala Alshammary, Angela A Amoako, Mahmoud H Awawda, Ariel J Raskin

N Engl J Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis